SCHEMBL6209878 — predicted protein targets

Known targets — ChEMBL curated mechanism

ABL1 ADRA1A ADRA1B ADRA1D ADRA2A ADRA2B ADRA2C ADRB2 AGTR1 BCL2 BCL2A1 BCL2L1 BCL2L10 BCL2L2 BCR BRAF CHRM1 CHRNA10 CHRNA9 DRD1 DRD2 DRD3 DRD4 DRD5 EGFR F2 FLT1 FLT4 GCK GHSR GNRHR GRIN1 GRIN2A GRIN2B GRIN2C GRIN2D GRIN3A GRIN3B HTR1A HTR1B HTR1D HTR2A HTR2C HTR3A IDH2 KDR KIT MAOB MCL1 MTTP P P4HB PDGFRB PIK3CA PIK3CB PIK3CD PIK3CG PIK3R1 PIK3R2 PIK3R3 PIK3R5 PIKFYVE ROCK1 ROCK2 SLC18A2 SLC6A2 SLC6A3 SLC6A4 TACR1 TUBA1A TUBA1B TUBA1C TUBA3C TUBA3E TUBA4A TUBB TUBB1 TUBB2A TUBB2B TUBB3 TUBB4A TUBB4B TUBB6 TUBB8 gyrA gyrB parC parE pol

The experimentally established mechanism targets of None. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 2)

	gene	UniProt	supporting neighbours	confidence
▸	MAPK14	Q16539	20/20	0.66

▸	CYP3A4	P08684	8/20	0.61

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compound	similarity	top predicted	shared targets
SCHEMBL6208992	0.97	MAPK14 (0.70)	MAPK14CYP3A4
SCHEMBL5770988	0.87	MAPK14 (0.77)	MAPK14CYP3A4
SCHEMBL5771924	0.81	MAPK14 (0.79)	MAPK14CYP3A4
SCHEMBL4840871	0.81	MAPK14 (0.67)	MAPK14CYP3A4
SCHEMBL4833591	0.81	MAPK14 (0.54)	MAPK14CYP3A4
SCHEMBL5772014	0.80	MAPK14 (0.85)	MAPK14CYP3A4
SCHEMBL4837413	0.79	MAPK14 (1.00)	MAPK14CYP3A4
SCHEMBL5771615	0.79	MAPK14 (0.73)	MAPK14CYP3A4
SCHEMBL5771391	0.79	MAPK14 (0.83)	MAPK14CYP3A4
SCHEMBL5771793	0.79	MAPK14 (0.83)	MAPK14CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

Patent	Title	Assignee	Published	Priority	Filing	Country	Status
EP-1554272-A1	BENZIMIDAZOLES AND BENZOTHIAZOLES AS INHIBITORS OF MAP KINASE	ELI LILLY AND COMPANY (US)	2005-07-20	—	—	EP	disclosed
WO-2004014900-A1	BENZIMIDAZOLES AND BENZOTHIAZOLES AS INHIBITORS OF MAP KINASE	ELI LILLY AND COMPANY (US)	2004-02-19	—	—	WO	disclosed